ArticlePharmaceutics2024

A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer.

Nora D Mineva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.